Sonnet Biotherapeutics Holdings

SONN · NASDAQ

$51.02+$51.02 (+0.00%)TodayMarket closed ·
Prev close $0.00

About SONN

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. The company went IPO on 2005-07-27. The Fully Human Albumin Binding (FHAB), a technology which utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its FHAB is designed to target tumors and lymphatic tissue. The firm's lead program, SON-1010 (IL-12-FHAB), is a single-chain version of human Interleukin 12 (IL-12), linked to the FHAB construct, for which pursuing clinical development in solid tumor indications, including ovarian cancer, soft tissue sarcoma, colorectal cancer, and breast cancer. Its SON-1210 (IL12-FHAB-IL15), is a bifunctional construct, combines FHAB with single-chain human IL-12 and human Interleukin 15 (IL-15). Its SON-080 is in development for Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN).

Employees
13
Headquarters
Princeton, New Jersey
Listed
Jul 27, 2005
Sector
Health Care
Industry
Biotechnology

Leadership

Sonnet Biotherapeutics Holdings executives
NameTitleSince
Raghu Rao—2020
Jenene Thomas—2025

Revenue by product and region

Fiscal year ended Dec 31, 2019: $30.14M total revenue

By product

  • Restaurant Sales, Net [Member]$29.06M96.4%
  • Franchise Income [Member]$575.09K1.9%
  • Gaming Income, Net [Member]$462.51K1.5%
  • Management Fee Income [Member]$50.00K0.2%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Sonnet Biotherapeutics Holdings suppliers and customers
CompanyRelationshipCorrelation
XOMA XOMASupplier and customer0.81
Merck MRK.DESupplier and customer-0.30
New Life Therapeutics Pte Ltd.Supplier and customer—

Similar companies

Companies in the same industry as Sonnet Biotherapeutics Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.